
The FDA has granted its approval to Natroba Topical Suspension 0.9%, a new treatment for controlling head lice.
According to the U.S. Centers for Disease Control and Prevention, there are between 6 to 12 million cases of head lice infestations each year, mostly in children 3 to 12 years old in the US. Head lice are contagious, blood-sucking parasites which leaps from head to head, going through an entire classroom in one day. The adult louse has developed a resistance to methods of killing it, making it very difficult to get rid of. The money spent to deal with this condition is as high as $1 billion per year in the US alone.
Nevertheless, this is the only effective treatment that is available now.
Source: Medindia
Advertisement
|
Recommended Reading
Latest General Health News




